MedPath

A Study to create an artificial intelligence based risk assessment model to detect deterioration of patients clinical status

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/09/027595
Lead Sponsor
Wipro GE Healthcare Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients admitted with suspected COVID-19 at AIIMS Rishikesh (irrespective of COVID Status) during the study period who are able and willing to give informed written consent (Signature/Thumb impression)

Exclusion Criteria

Unable or unwilling to give informed consent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proof of concept Artificial Intelligence based Risk assessment modelTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
Testing of iterated model in the clinical setting on prospectively collected datasetsTimepoint: 16 weeks
© Copyright 2025. All Rights Reserved by MedPath